Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.47
Delayed Data
As of Sep 29
 -0.0201 / -4.10%
Today’s Change
0.46
Today|||52-Week Range
2.80
-61.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2008

2009

2010

2011
Operating ActivitiesNet Income / Starting Line-4.2M-5.5M-12.6M-14.7M
 
 
 
 
 
Depreciation89.0K50.0K52.0K75.0K
 
 
 
 
 
Total Other Cash Flow-3.9M380.0K5.6M-6.2M
 
 
 
 
 
Funds From Operations-8.1M-5.0M-6.9M-20.8M
 
 
 
 
 
Funds From/For Other Operating Expenses4.3M-39.9M19.9M-535.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-12.3M34.9M-26.8M-20.3M
 
 
 
 
 
 
InvestingIncrease In Investments-4.8M-4.0M-93.0M-75.1M
 
 
 
 
 
Decrease In Investments15.3M6.3M34.0M100.3M
 
 
 
 
 
Capital Expenditures-3.0K-15.0K-68.0K-79.0K
 
 
 
 
 
Other Investing - Uses-807.0K--0.000.00
 
 
Other Investing - Sources5.5M--0.000.00
 
 
Net Cash Flow Investing15.1M2.2M-59.1M25.1M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings----0.000.00--
Long Term Debt Reduction----0.000.00--
Net Proceeds Stock Sale124.0K17.3M47.5M219.0K
 
 
 
 
 
Common Preferred Redeemed----0.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----0.000.00--
Other Uses - Financing3.0K--0.000.00
 
 
Net Cash Flow - Financing121.0K17.3M47.5M219.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash90.0K-21.0K-33.0K-40.0K
 
 
 
 
 
 
Net Change In Cash2.9M54.5M-38.5M5.0M